PEPTIDES ET PEPTIDOMIMÉTIQUES EN COMBINAISON AVEC DES AGENTS ACTIVATEURS DE CELLULES T ET/OU INHIBITEURS DE POINTS DE CONTRÔLE POUR LE TRAITEMENT DU CANCER
This invention provides compounds including peptides and peptidomimetics that can be used to treat cell proliferative disorders, such as those associated with benign and malignant tumor cells, and combinations of T cell activating agents and/or an immune checkpoint inhibitors with and without peptides and peptidimimetics. The invention compounds and combinations can be used to inhibit cell growth, such as treat a tumor or cancer.